Glycosaminoglycans inhibit the antibacterial activity of LL-37 in biological fluids

W Baranska-Rybak, Andreas Sonesson, R Nowicki, Artur Schmidtchen

Research output: Contribution to journalArticlepeer-review


Objectives: The antibacterial activity of antimicrobial peptides is influenced by various factors such as salt content, pH and the presence of proteins. In this study, we explored the antibacterial action of the human cathelicidin LL-37 in physiologically relevant conditions, i.e. various human wound fluids, human plasma fractions and serum. Methods: Radial diffusion assays using Staphylococcus aureus and Escherichia coli were employed for the study of antibacterial effects of LL-37 in the presence of 12 different wound fluids, citrate-, heparin- or EDTA-plasma, or human serum. Glycosaminoglycan content of wound fluids was determined by an Alcian Blue-binding assay. Protein content of wound fluids was measured by the Bradford method. A slot-binding assay was used to study the effects of inhibitors on the interaction between LL-37 and glycosaminoglycans. Results: Five of twelve wound fluids derived from acute wounds showed marked inhibitory effects on the antibacterial action of LL-37. The inhibition was significantly correlated with high glycosaminoglycan content in wound fluid. Analogous to these findings, heparin-plasma strongly inhibited the antibacterial effect of LL-37. The interaction between LL-37 and glycosaminoglycans was abrogated by the cationic polymers DEAE-dextran and chitosan, yielding increased activity of LL-37. Conclusions: Glycosaminoglycan-rich biological fluids inhibit the antibacterial effects of LL-37. Furthermore, polycations that bind to glycosaminoglycans increase the antibacterial activities of endogenous antimicrobial peptides in glycosaminoglycan-containing biological fluids.
Original languageEnglish
Pages (from-to)260-265
JournalJournal of Antimicrobial Chemotherapy
Issue number2
Publication statusPublished - 2006

Subject classification (UKÄ)

  • Pharmacology and Toxicology


  • plasma
  • wound fluids
  • bacteria
  • serum
  • antibacterial peptides


Dive into the research topics of 'Glycosaminoglycans inhibit the antibacterial activity of LL-37 in biological fluids'. Together they form a unique fingerprint.

Cite this